Cargando…
Dapagliflozin Improves Cardiac Hemodynamics and Mitigates Arrhythmogenesis in Mitral Regurgitation‐Induced Myocardial Dysfunction
BACKGROUND: Mitral regurgitation (MR) is a major contributor for heart failure (HF) and atrial fibrillation. Despite the advancement of MR surgeries, an effective medical therapy to mitigate MR progression is lacking. Sodium glucose cotransporter 2 inhibitors, a new class of antidiabetic drugs, has...
Autores principales: | Lin, Yu‐Wen, Chen, Chin‐Yu, Shih, Jhih‐Yuan, Cheng, Bor‐Chih, Chang, Ching‐Ping, Lin, Mao‐Tsun, Ho, Chung‐Han, Chen, Zhih‐Cherng, Fisch, Sudeshna, Chang, Wei‐Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174384/ https://www.ncbi.nlm.nih.gov/pubmed/33749310 http://dx.doi.org/10.1161/JAHA.120.019274 |
Ejemplares similares
-
Mineralocorticoid Receptor Antagonists Mitigate Mitral Regurgitation-Induced Myocardial Dysfunction
por: Chang, Wei-Ting, et al.
Publicado: (2022) -
Effects of Adrenomedullin on Atrial Electrophysiology and Pulmonary Vein Arrhythmogenesis
por: Chin, Chye-Gen, et al.
Publicado: (2022) -
Role of Endothelin-1 in Right Atrial Arrhythmogenesis in Rabbits with Monocrotaline-Induced Pulmonary Arterial Hypertension
por: Lu, Yen-Yu, et al.
Publicado: (2022) -
Glucagon-like Peptide-1 Receptor Activation Reduces Pulmonary Vein Arrhythmogenesis and Regulates Calcium Homeostasis
por: Chan, Chao-Shun, et al.
Publicado: (2023) -
Electrical and Structural Insights into Right Ventricular Outflow Tract Arrhythmogenesis
por: Lu, Yen-Yu, et al.
Publicado: (2023)